Anteilseigner
Capital Research & Management Co. (World Investors) (11,46 %) BlackRock Fund Advisors (6,45 %) GIC Pte Ltd. (Investment Management) (5,59 %) Palo Alto Investors LP (5,03 %) The Vanguard Group, Inc. (4,64 %) Franklin Advisers, Inc. (4,52 %) Polar Capital LLP (3,04 %) JPMorgan Investment Management, Inc. (2,46 %) SSgA Funds Management, Inc. (2,42 %) Geode Capital Management LLC (1,85 %) JPMorgan Asset Management (UK) Ltd. (1,82 %) Invesco Advisers, Inc. (1,46 %) Rubric Capital Management LP (1,40 %) Walleye Capital LLC (0,93 %) Deerfield Management Co. LP (Private Equity) (0,83 %) Northern Trust Investments, Inc.(Investment Management) (0,80 %) Rice, Hall, James & Associates LLC (0,72 %)
Kontakt
Revance Therapeutics Inc.